Page last updated: 2024-12-06

guacetisal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guacetisal: tolerated by patients with aspirin-asthma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68749
CHEMBL ID2105097
CHEBI ID135185
SCHEMBL ID948974
MeSH IDM0080952

Synonyms (35)

Synonym
D07292
guacetisal (inn)
prontomucil (tn)
55482-89-8
guacetisalum [inn-latin]
broncaspin
guacetisal
o-methoxyphenyl salicylate acetate
einecs 259-663-1
aspirin guaiacol ester
benzoic acid, 2-(acetyloxy)-, 2-methoxyphenyl ester
guacetisal [inn]
CHEBI:135185
(2-methoxyphenyl) 2-acetyloxybenzoate
2-methoxyphenyl 2-acetoxybenzoate
t6ekb9v2o2 ,
unii-t6ekb9v2o2
guacetisalum
prontomucil
CHEMBL2105097
AKOS016013942
guacetisal [mart.]
aspirin guaiacol ester [mi]
guacetisal [who-dd]
SCHEMBL948974
CS-7899
DTXSID40204060
HY-17477
DS-6467
mfcd00864354
DB13538
BCP13585
Q1028455
O10824
A913310

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbonyl compoundAny compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (90.32)18.7374
1990's3 (9.68)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.30 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials21 (67.74%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (32.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]